Patent & IP news for May 20, 2015

Patent Litigations

USPTO Weekly Stats

7,065
published
appl'ns
6,166
granted
patents
64
ptab
decisions

Patent & IP Blogs

post image Copyrighting Your Patent? from patentlyo.com

by Dennis Crouch Although it sounds of a malformed naive question, at times patent applicants do want to copyright their patent.  The patent application may, for instance, include software code, prose, or particular schematics that ...

Share via E–mail | Twitter | Facebook

post image The Unitary Patent and Unified Patent Court: new survey seeks responses from patlit.blogspot.com

Nick Cunningham (Wragge Lawrence Graham & Co.) has written to tell us that his firm is running a survey to try to find out what patent owners and their advisers are planning to do about the ...

Share via E–mail | Twitter | Facebook

Biogen MA, Inc. v. Japanese Foundation for Cancer Research (Fed. Cir. 2015) from www.patentdocs.org

By Kevin E. Noonan -- The Federal Circuit affirmed a decision by the U.S. District Court for the District of Massachusetts that it lacked subject matter jurisdiction under 35 U.S.C. § 146 pursuant to ...

Share via E–mail | Twitter | Facebook

CAFC on Apple v. Samsung on 18 May 2015 from ipbiz.blogspot.com



--
A jury found that Samsung
infringed Apple’s design and utility patents
and diluted Apple’s trade dresses.
For the reasons that follow, we affirm the jury’s verdict on the
design patent infringements, the ...

Share via E–mail | Twitter | Facebook

US 9,034,619 to DEINOVE titled Recombinant bacteria and the uses thereof for producing ethanol from ipbiz.blogspot.com

The first published claim of US '619:

--
A recombinant Deinococcus bacterium comprising a recombinant nucleic acid construct encoding a pyruvate decarboxylase (PDC) from Zymomonas and an alcohol dehydrogenase (ADH) from Zymomonas, wherein the PDC and ...

Share via E–mail | Twitter | Facebook

On judges seeking guidance from ipbiz.blogspot.com

Note the article by Benjamin Reiser titled:

--
Faced With Legal Puzzles, Judges Often Turn to Fellow Jurists

--

which includes

--
The judges interviewed said they would not seek guidance from an outside source, like a law ...

Share via E–mail | Twitter | Facebook

Did The WHO Just Invite Corporates To Set Health Policy? from www.ip-watch.org

From the New Minute: The Director General of the World Health Organisation (WHO) Dr. Margaret Chan has invited the private sector, civil society and academia among others, to join a dialogue on how non-state players ...

Share via E–mail | Twitter | Facebook

Apple's US application 20150070276: Transparent Electronic Device from ipbiz.blogspot.com

The first published claim:

--
A portable electronic device, comprising: a housing; a display comprising first and second overlapping display screens disposed within the housing; a motion sensor; and a processor disposed within the housing, wherein ...

Share via E–mail | Twitter | Facebook

Horological Horror Show for Swatch, while Panavision has a Ball from ipkitten.blogspot.com

In its decision yesterday, the General Court of the European Union warmed up with a case on reputation in what is expected to be a hot week for trade mark decisions. The Court was requested ...

Share via E–mail | Twitter | Facebook

Misconduct of Plaintiff's Lead Trial Counsel Does Not Warrant New Trial from docketreport.blogspot.com

Despite finding attorney misconduct, the court denied defendant's motion for a new trial and rejected the argument that plaintiff tainted the jury verdict by discussing the results of another case involving one of the ...

Share via E–mail | Twitter | Facebook

Digital Technologies and the Scope of Regulation: How Does Regulation Apply to Over-the-Top Players Like Google and WhatsApp? from www.iposgoode.ca

The re-posting of this analysis is part of a cross-posting collaboration with MediaLaws: Law and Policy of the Media in a Comparative Perspective. The explosion of digital services delivered via telecommunication networks is creating a ...

Share via E–mail | Twitter | Facebook

NATURE gets it wrong on patent reform bills from ipbiz.blogspot.com

The post in the journal Nature titled

--
Congress seeks to quash patent trolls

Revised legislation would spare universities from being penalized in the same way as unscrupulous companies.


--

incorrectly relates the Senate PATENT Act and ...

Share via E–mail | Twitter | Facebook

Federal Circuit Again Addresses “Divided Infringement” Scenarios from patlit.blogspot.com

On May 13, 2015, the U.S. Court of Appeals for the Federal Circuit again considered the circumstances in which a defendant may be liable for direct infringement under 35 U.S.C. § 271(a ...

Share via E–mail | Twitter | Facebook

Clean Tech in Court: Green Patent Complaint Update from www.greenpatentblog.com

A number of new green patent complaints were filed in the last two months in the areas of energy storage, LED lighting, and smart grid (including lighting control).   Energy Storage Power Regeneration, LLC v. Siemens ...

Share via E–mail | Twitter | Facebook

Patent Quality. from patentlyo.com

Somewhat interesting to me that the USPTO self-reported quality numbers are way-down for FY2015.  I have not yet followed-up, but my initial guess is that the change is a measurement change rather than a change ...

Share via E–mail | Twitter | Facebook

Breaking News: New Act Protecting Geographical Indications Adopted At WIPO; Some Denounce Process from www.ip-watch.org

Today, a small number of World Intellectual Property Organization members adopted a new Geneva Act of a treaty protecting appellations of origin and geographical indications. The Act is the revision of a previous treaty which ...

Share via E–mail | Twitter | Facebook

Offering Compassionate Care While Alleviating Ethical Concerns: How Some Pharmaceutical Companies Are Meeting Both Demands from www.iplawalert.com

In recent years, families and friends of terminally ill patients have launched highly visible social media campaigns to secure access to potentially life-saving medicine, before those experimental drugs are approved. Pharmaceutical companies that are developing ...

Share via E–mail | Twitter | Facebook

Five Challenges Filed Against Gilead Patent Claims For Hepatitis C Drug from www.ip-watch.org

Pharmaceutical company Gilead Sciences has been noted first for developing a treatment for hepatitis C, which afflicts tens of millions around the world, and then for pricing it at jaw-dropping prices ($1000 per pill) in ...

Share via E–mail | Twitter | Facebook

Some content © 2007–2015 RPX Corporation.
Terms of Service & Privacy Policy
For DMCA requests contact help@priorsmart.com.